IMPACT OF EARLY SUCCESSFUL PPCI ON LEFT VENTRICULAR EJECTION FRACTION AMONG STEMI CASES

S KAMAL; AS KHAN; UE EMMAN; SA KHAN; . ADEEL; K QAZI

doi:10.54112/bcsrj.v2024i1.1249

Authors

S KAMAL Peshawar Institute of Cardiology, Pakistan
AS KHAN Rehman Medical Institute, Pakistan
UE EMMAN Rehman Medical Institute, Pakistan
SA KHAN Rehman Medical Institute, Pakistan
. ADEEL Hayatabad Medical Complex Peshawar, Pakistan
K QAZI Hayatabad Medical Complex Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1249

Keywords:

STEMI, primary percutaneous coronary intervention, left ventricular ejection fraction, TIMI flow, early intervention, major adverse cardiac events

Abstract

Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, making holistic health management essential for patients. Psychological well-being, particularly stress, depression, and anxiety management, is critical for effective CVD rehabilitation. Interventions focused on stress management hold promise for reducing these negative psychological impacts, thereby enhancing patient health and recovery Objective: T o determine the early impact of successful primary percutaneous coronary intervention (PPCI) on left ventricular ejection fraction (LVEF) and clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI). Methods: This study included 60 STEMI patients who underwent PPCI from July 2023 to July 2024. Patients were included if presented within 6 hours of onset of symptom. LVEF was assessed at presentation and six months post-PPCI. The post-procedural TIMI flow grade was recorded. Data on patient demographics, comorbidities, and procedural outcomes were collected. Results: The mean age was 59.57 ± 10.46 years, with 71.7% male. LVEF at presentation was 36.70 ± 4.76%, which significantly improved to 54.88 ± 2.73% at six months (p = 0.0001). Post-PPCI, 66.7% of patients achieved TIMI grade 3 flow, and 33.3% had TIMI grade 2 flow. In-hospital mortality was 3.3%, and major adverse cardiac events (MACE) occurred in 5% of patients. Conclusion: Early successful PPCI in STEMI patients results in significant improvement in LVEF and favorable clinical outcomes.

Downloads

Download data is not yet available.

References

Pascual I, Avanzas P, Almendárez M, Lorca R, Vigil-Escalera M, Arboine L, et al. STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study. Revista Española de Cardiología (English Edition). 2021;74(10):829-37.

Wollmuth J, Patel MP, Dahle T, Bharadwaj A, Waggoner TE, Chambers JW, et al. Ejection fraction improvement following contemporary high-risk percutaneous coronary intervention: RESTORE EF study results. Journal of the Society for Cardiovascular Angiography & Interventions. 2022;1(5):100350.

Fernando H, Dinh D, Duffy SJ, Brennan A, Sharma A, Clark D, et al. Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry. IJC Heart & Vasculature. 2021;33:100745.

Duque ER, Briasoulis A, Alvarez PA. Heart failure with preserved ejection fraction in the elderly: pathophysiology, diagnostic and therapeutic approach. Journal of geriatric cardiology: JGC. 2019;16(5):421.

Kamiya M, Sato N, Matsuda J, Nozaki A, Akiya M, Sato T, et al. Predictors of responders for low-dose carperitide monotherapy in patients with acute heart failure. Heart and Vessels. 2020;35(1):59-68.

Craig JC, Colburn TD, Caldwell JT, Hirai DM, Tabuchi A, Baumfalk DR, et al. Central and peripheral factors mechanistically linked to exercise intolerance in heart failure with reduced ejection fraction. American Journal of Physiology-Heart and Circulatory Physiology. 2019;317(2):H434-H44.

Melo X, Abreu A, Santos V, Cunha P, Oliveira M, Pinto R, et al. A Post hoc analysis on rhythm and high intensity interval training in cardiac resynchronization therapy. Scandinavian Cardiovascular Journal. 2019;53(4):197-205.

Hendrickson MJ, Arora S, Vaduganathan M, Fonarow GC, Mp G, Bansal A, et al. Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India. ESC heart failure. 2022;9(6):3836-45.

Mahdavi-Roshan M, Ghorbani Z, Gholipour M, Salari A, Savar Rakhsh A, Kheirkhah J. Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction (LVEF) in patients with ST-elevation myocardial infarction (STEMI). BMC Cardiovascular Disorders. 2022;22(1):224.

Xing Z, Tang L, Huang J, Peng X, Hu X. Effects of ischaemic postconditioning on outcomes of patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention: a meta-analysis. BMJ open. 2019;9(3):e022509.

Alimohammadzadeh K, Sadeghi R, Maher A, Kazemi MK. Short-term cost-effectiveness of reteplase versus primary percutaneous coronary intervention in patients with acute STEMI a tertiary hospital in Iran. International Journal of Cardiovascular Practice. 2017;2(3):65-9.

Liu J, Wang H, Li J. Inflammation and inflammatory cells in myocardial infarction and reperfusion injury: a double-edged sword. Clinical Medicine Insights: Cardiology. 2016;10:CMC. S33164.

Haq MR, Tareen M, Tareen M, Hakeem A, Kumar R, Saghir T, et al. The Impact of Early Successful Primary Percutaneous Coronary Intervention on Left Ventricular Systolic Function in ST Elevation Myocardial Infarction Patients. Pakistan Journal of Cardiovascular Intervention. 2022;2(1):06-10.

Rakowski T, Zalewski J, Legutko J, Bartus S, Rzeszutko L, Dziewierz A, et al. Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study. American heart journal. 2007;153(3):360-5.

Roshdy S, Talaat M, Abdelsabour M. In-Hospital Outcomes after Primary Percutaneous Coronary Intervention in Association with Left Ventricular Ejection Fraction. The Egyptian Journal of Hospital Medicine. 2022;89(1):5165-70.